Augmenting the synergies of chemotherapy and immunotherapy through drug delivery-Reference-Cited by-同舟云学术

Augmenting the synergies of chemotherapy and immunotherapy through drug delivery

Published:2019-04 Issue: Volume:88 Page:1-14
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Kim Jihoon,Manspeaker Margaret P.,Thomas Susan N.

Funder

Susan G. Komen

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference131 articles.

1. A history of cancer chemotherapy;DeVita;Cancer Res.,2008

2. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the Antitumor Agent Smancs;Matsumura;Cancer Res.,1986

3. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo;Maeda;Adv. Drug Deliv. Rev.,2013

4. A retrospective 30 years after discovery of the enhanced permeability and retention effect of solid tumors: next-generation chemotherapeutics and photodynamic therapy-problems solutions, and prospects;Maeda;Microcirculation,2016

5. Nanotherapeutics to overcome conventional cancer chemotherapy limitations;Moorthi;J. Pharm. Pharm. Sci.,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Anticancer Effects of Intratumorally Injected Electrostatic Doxorubicin‐Loaded Click‐Type Crosslinked Hyaluronic Acid Hydrogel;Advanced Therapeutics;2024-09-02

2. Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer;Current Treatment Options in Oncology;2024-07-27

3. Nanoparticle-mediated immunogenic cell death for cancer immunotherapy;International Journal of Pharmaceutics;2024-05

4. Benefits of camrelizumab plus carboplatin and albumin paclitaxel as induction therapy for locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma;Thoracic Cancer;2024-02-05

5. Chitosan and hyaluronic acid-based nanocarriers for advanced cancer therapy and intervention;Biomaterials Advances;2024-02